Sarah Sammons, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared on LinkedIn:
“Day 3 ESMO Breast Cancer Updates.
New standard of care= Trop2 ADCs in first line IO ineligible Metastatic TNBC.”
ESMO 2025 Day 1 Highlights Not to Miss
ESMO 2025 Day 2 Highlights Not to Miss
ESMO 2025 Day 3 Highlights Not to Miss
